Works matching AU Garcia-Azorin, David
Results: 103
Facial epicrania fugax: A prospective series of eight new cases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01448-2
- By:
- Publication type:
- Article
Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01324-5
- By:
- Publication type:
- Article
Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01268-w
- By:
- Publication type:
- Article
Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01165-8
- By:
- Publication type:
- Article
White matter changes in chronic and episodic migraine: a diffusion tensor imaging study.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-019-1071-3
- By:
- Publication type:
- Article
Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00569-8
- By:
- Publication type:
- Article
Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 9, p. 4437, doi. 10.1007/s10072-024-07483-y
- By:
- Publication type:
- Article
The cognitive impact of guard shifts in physicians: a before-after study.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 3, p. 1701, doi. 10.1007/s10072-021-05501-x
- By:
- Publication type:
- Article
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 12, p. 5087, doi. 10.1007/s10072-021-05180-8
- By:
- Publication type:
- Article
COVID-19 and neurological training in Europe: from early challenges to future perspectives.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 12, p. 3377, doi. 10.1007/s10072-020-04723-9
- By:
- Publication type:
- Article
Alternative Microstructural Measures to Complement Diffusion Tensor Imaging in Migraine Studies with Standard MRI Acquisition.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 10, p. 711, doi. 10.3390/brainsci10100711
- By:
- Publication type:
- Article
Post–COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 11, p. e2242106, doi. 10.1001/jamanetworkopen.2022.42106
- By:
- Publication type:
- Article
Treatment of Primary Nummular Headache: A Series of 183 Patients from the NUMITOR Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 122, doi. 10.3390/jcm12010122
- By:
- Publication type:
- Article
Communicate your findings with graphical abstract in Cephalalgia : Why and how?
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine.
- Published in:
- Cephalalgia, 2024, v. 44, n. 12, p. 1, doi. 10.1177/03331024241262751
- By:
- Publication type:
- Article
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society.
- Published in:
- Cephalalgia, 2024, v. 44, n. 11, p. 1, doi. 10.1177/03331024241297688
- By:
- Publication type:
- Article
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine.
- Published in:
- Cephalalgia, 2024, v. 44, n. 9, p. 1, doi. 10.1177/03331024241269735
- By:
- Publication type:
- Article
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine.
- Published in:
- Cephalalgia, 2024, v. 44, n. 8, p. 1, doi. 10.1177/03331024241252666
- By:
- Publication type:
- Article
It is a long way to the top if you wanna citations?
- Published in:
- Cephalalgia, 2024, v. 44, n. 5, p. 1, doi. 10.1177/03331024241251487
- By:
- Publication type:
- Article
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine.
- Published in:
- Cephalalgia, 2024, v. 44, n. 4, p. 1, doi. 10.1177/03331024241248833
- By:
- Publication type:
- Article
InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection.
- Published in:
- Cephalalgia, 2023, v. 43, n. 11, p. 1, doi. 10.1177/03331024231212900
- By:
- Publication type:
- Article
Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up.
- Published in:
- Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231201576
- By:
- Publication type:
- Article
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.
- Published in:
- Cephalalgia, 2023, v. 43, n. 4, p. 1, doi. 10.1177/03331024231159366
- By:
- Publication type:
- Article
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review.
- Published in:
- Cephalalgia, 2023, v. 43, n. 1, p. 1, doi. 10.1177/03331024221131337
- By:
- Publication type:
- Article
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports.
- Published in:
- Cephalalgia, 2022, v. 42, n. 11/12, p. 1207, doi. 10.1177/03331024221099231
- By:
- Publication type:
- Article
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients.
- Published in:
- Cephalalgia, 2022, v. 42, n. 8, p. 804, doi. 10.1177/03331024211068074
- By:
- Publication type:
- Article
The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
- Published in:
- Cephalalgia, 2021, v. 41, n. 13, p. 1332, doi. 10.1177/03331024211020404
- By:
- Publication type:
- Article
Time lost due to an attack – a novel patient-reported outcome measure for acute migraine treatments.
- Published in:
- Cephalalgia, 2021, v. 41, n. 9, p. 1027, doi. 10.1177/03331024211006048
- By:
- Publication type:
- Article
Management of thunderclap headache in the emergency room: A retrospective cohort study.
- Published in:
- Cephalalgia, 2021, v. 41, n. 6, p. 711, doi. 10.1177/0333102420981721
- By:
- Publication type:
- Article
Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Paroxysmal headache with extracephalic irradiation: Proposal for a new variant of epicrania fugax in a series of five patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Structural connectivity alterations in chronic and episodic migraine: A diffusion magnetic resonance imaging connectomics study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Epicrania Fugax as the presenting symptom of a cerebellar abscess.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-world experience of galcanezumab in the prevention of migraine in Spain: a systematic literature review.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1502475
- By:
- Publication type:
- Article
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti‐calcitonin gene‐related peptide therapies: The PREVENAC study.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 5, p. 1, doi. 10.1111/ene.16215
- By:
- Publication type:
- Article
RE‐START: Exploring the effectiveness of anti‐calcitonin gene‐related peptide resumption after discontinuation in migraine.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 4, p. 1, doi. 10.1111/ene.16203
- By:
- Publication type:
- Article
Machine‐learning‐based approach for predicting response to anti‐calcitonin gene‐related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 10, p. 3102, doi. 10.1111/ene.15458
- By:
- Publication type:
- Article
Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 11, p. 3820, doi. 10.1111/ene.15040
- By:
- Publication type:
- Article
Neurology training and research in the COVID‐19 pandemic: a survey of the Resident and Research Fellow Section of the European Academy of Neurology.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 10, p. 3437, doi. 10.1111/ene.14696
- By:
- Publication type:
- Article
Headache education and management in Cameroon: a healthcare provider study.
- Published in:
- Acta Neurologica Belgica, 2022, v. 122, n. 1, p. 75, doi. 10.1007/s13760-021-01620-6
- By:
- Publication type:
- Article
Association of dynamic and widespread mechanical sensitivity in cluster headache.
- Published in:
- Acta Neurologica Belgica, 2020, v. 120, n. 5, p. 1265, doi. 10.1007/s13760-020-01450-y
- By:
- Publication type:
- Article
Physical activity as a predictor of fremanezumab response in chronic migraine – the Phy-Fre-Mig study.
- Published in:
- Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-01965-w
- By:
- Publication type:
- Article
Combining treatments for migraine prophylaxis: the state-of-the-art.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01925-w
- By:
- Publication type:
- Article
Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members' vision – part 2.
- Published in:
- Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-024-01944-7
- By:
- Publication type:
- Article
Hallmarks of primary headache: part 1 – migraine.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01889-x
- By:
- Publication type:
- Article
Differential Diagnosis of Visual Phenomena Associated with Migraine: Spotlight on Aura and Visual Snow Syndrome.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 2, p. 252, doi. 10.3390/diagnostics13020252
- By:
- Publication type:
- Article
Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study.
- Published in:
- Toxins, 2022, v. 14, n. 12, p. 850, doi. 10.3390/toxins14120850
- By:
- Publication type:
- Article